Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Aurora Cannabis Inc.TSX: ACB.TO

Weighted Avg Shares · Q4 FY2026 · quarter ended Mar 2026

Weighted avg shares grows in line with its trailing trend

Q4 FY2026 weighted avg shares of 57.47M shares rose 4.7% year over year, ahead of the +4.2% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 1.4% from the prior quarter. Over 3 fiscal years it compounded at +20.7% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2026 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +4.7% holds above the trailing-twelve-month pace of +4.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
57.47M+1.4% QoQ
Last fiscal yearMar 2026
56.71M+3.3% YoY
LTMMar 2026
56.32M+4.2% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+4.7%——
1 year+3.3%——
3-year CAGR+20.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2026
56.71M CAD
Year-over-year change
+3.3%
4-year CAGR
+27.5%

Weighted Avg Shares vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • ACB.TO's LTM Mar 2026 weighted avg shares of 56.32M shares is the 6th highest of the 8 companies compared; the peer median is 288.35M shares.
  • Its year-over-year change of +4.2% is the 6th highest of 8, against a peer median of +9.1%.
  • Over three fiscal years its annual growth of +20.7% compares with a peer median of +5.0%.
ACB.TO Competitors Peer median
Weighted Avg Shares for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR
XLY.TOAuxly Cannabis Group Inc.LTM Mar 20261.35B +5.3%+14.3%
TSND.TOTerrAscend Corp.LTM Mar 2026305.61M +9.1%+7.2%
EDT.TOSpectral Medical Inc.LTM Mar 2026289.2M +2.4%+2.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026288.35M +167.7%+8.4%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026133.64M +18.4%—
ACB.TOAurora Cannabis Inc.LTM Mar 202656.32M +4.2%+20.7%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 202630.27M +10.4%+2.8%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202625.45M +1.1%+0.5%
Peer median (excluding ACB.TO) 288.35M+9.1%+5.0%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.